A multicenter study evaluating mutational profiling of ALK+ non-small cell lung cancer patients with acquired resistance to crizotinib
Latest Information Update: 08 Jan 2019
At a glance
- Drugs Crizotinib (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
Most Recent Events
- 08 Jan 2019 New trial record